List of Tables
Table 1. Global Expectorant Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Expectorant Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Expectorant Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Expectorant Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Expectorant Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Expectorant Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Expectorant Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Expectorant Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Expectorant Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Expectorant Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Expectorant Drug, Product Type & Application
Table 12. Global Key Manufacturers of Expectorant Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Expectorant Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expectorant Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Expectorant Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Expectorant Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Expectorant Drug Sales Market Share by Region (2019-2024)
Table 19. Global Expectorant Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Expectorant Drug Sales Market Share by Region (2025-2030)
Table 21. Global Expectorant Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Expectorant Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Expectorant Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Expectorant Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Expectorant Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Expectorant Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Expectorant Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Expectorant Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Expectorant Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Expectorant Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Expectorant Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Expectorant Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Expectorant Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Expectorant Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Expectorant Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Expectorant Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Expectorant Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Expectorant Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Expectorant Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Expectorant Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Expectorant Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Expectorant Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Expectorant Drug Sales Market Share by Type (2019-2024)
Table 53. Global Expectorant Drug Sales Market Share by Type (2025-2030)
Table 54. Global Expectorant Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Expectorant Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Expectorant Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Expectorant Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Expectorant Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Expectorant Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Expectorant Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Expectorant Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Expectorant Drug Sales Market Share by Application (2019-2024)
Table 63. Global Expectorant Drug Sales Market Share by Application (2025-2030)
Table 64. Global Expectorant Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Expectorant Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Expectorant Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Expectorant Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Expectorant Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Expectorant Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Laboratories Expectorant Drug Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Acella Pharmaceuticals LLC Corporation Information
Table 76. Acella Pharmaceuticals LLC Description and Business Overview
Table 77. Acella Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Acella Pharmaceuticals LLC Expectorant Drug Product
Table 79. Acella Pharmaceuticals LLC Recent Developments/Updates
Table 80. Astrazeneca Plc. Corporation Information
Table 81. Astrazeneca Plc. Description and Business Overview
Table 82. Astrazeneca Plc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Astrazeneca Plc. Expectorant Drug Product
Table 84. Astrazeneca Plc. Recent Developments/Updates
Table 85. Cipla Limited Corporation Information
Table 86. Cipla Limited Description and Business Overview
Table 87. Cipla Limited Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Cipla Limited Expectorant Drug Product
Table 89. Cipla Limited Recent Developments/Updates
Table 90. Dabur India Ltd Corporation Information
Table 91. Dabur India Ltd Description and Business Overview
Table 92. Dabur India Ltd Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dabur India Ltd Expectorant Drug Product
Table 94. Dabur India Ltd Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Limited Corporation Information
Table 96. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 97. Glenmark Pharmaceuticals Limited Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Glenmark Pharmaceuticals Limited Expectorant Drug Product
Table 99. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 100. lohnson and Johnson Corporation Information
Table 101. lohnson and Johnson Description and Business Overview
Table 102. lohnson and Johnson Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. lohnson and Johnson Expectorant Drug Product
Table 104. lohnson and Johnson Recent Developments/Updates
Table 105. Merck KGaA Corporation Information
Table 106. Merck KGaA Description and Business Overview
Table 107. Merck KGaA Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merck KGaA Expectorant Drug Product
Table 109. Merck KGaA Recent Developments/Updates
Table 110. Novartis International AG Corporation Information
Table 111. Novartis International AG Description and Business Overview
Table 112. Novartis International AG Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Novartis International AG Expectorant Drug Product
Table 114. Novartis International AG Recent Developments/Updates
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Business Overview
Table 117. Pfizer Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Inc. Expectorant Drug Product
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Proctor and Gamble Co Corporation Information
Table 121. Proctor and Gamble Co Description and Business Overview
Table 122. Proctor and Gamble Co Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Proctor and Gamble Co Expectorant Drug Product
Table 124. Proctor and Gamble Co Recent Developments/Updates
Table 125. Reckitt Benckiser Group plc Corporation Information
Table 126. Reckitt Benckiser Group plc Description and Business Overview
Table 127. Reckitt Benckiser Group plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Reckitt Benckiser Group plc Expectorant Drug Product
Table 129. Reckitt Benckiser Group plc Recent Developments/Updates
Table 130. Sanofi SA Corporation Information
Table 131. Sanofi SA Description and Business Overview
Table 132. Sanofi SA Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sanofi SA Expectorant Drug Product
Table 134. Sanofi SA Recent Developments/Updates
Table 135. The Himalaya Drug Company Corporation Information
Table 136. The Himalaya Drug Company Description and Business Overview
Table 137. The Himalaya Drug Company Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. The Himalaya Drug Company Expectorant Drug Product
Table 139. The Himalaya Drug Company Recent Developments/Updates
Table 140. Perrigo Company plc Corporation Information
Table 141. Perrigo Company plc Description and Business Overview
Table 142. Perrigo Company plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Perrigo Company plc Expectorant Drug Product
Table 144. Perrigo Company plc Recent Developments/Updates
Table 145. Vernalis plc Corporation Information
Table 146. Vernalis plc Description and Business Overview
Table 147. Vernalis plc Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Vernalis plc Expectorant Drug Product
Table 149. Vernalis plc Recent Developments/Updates
Table 150. Tris Pharma Inc. Corporation Information
Table 151. Tris Pharma Inc. Description and Business Overview
Table 152. Tris Pharma Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Tris Pharma Inc. Expectorant Drug Product
Table 154. Tris Pharma Inc. Recent Developments/Updates
Table 155. Aytu BioScience Inc. Corporation Information
Table 156. Aytu BioScience Inc. Description and Business Overview
Table 157. Aytu BioScience Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Aytu BioScience Inc. Expectorant Drug Product
Table 159. Aytu BioScience Inc. Recent Developments/Updates
Table 160. Mayne Pharma Inc. Corporation Information
Table 161. Mayne Pharma Inc. Description and Business Overview
Table 162. Mayne Pharma Inc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Mayne Pharma Inc. Expectorant Drug Product
Table 164. Mayne Pharma Inc. Recent Developments/Updates
Table 165. Taro Pharmaceutical Industries Ltd. Corporation Information
Table 166. Taro Pharmaceutical Industries Ltd. Description and Business Overview
Table 167. Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product
Table 169. Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 170. Amneal Pharmaceuticals LLC Corporation Information
Table 171. Amneal Pharmaceuticals LLC Description and Business Overview
Table 172. Amneal Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Amneal Pharmaceuticals LLC Expectorant Drug Product
Table 174. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 175. Aurobindo Pharma Ltd Corporation Information
Table 176. Aurobindo Pharma Ltd Description and Business Overview
Table 177. Aurobindo Pharma Ltd Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Aurobindo Pharma Ltd Expectorant Drug Product
Table 179. Aurobindo Pharma Ltd Recent Developments/Updates
Table 180. GlaxoSmithKline plc. Corporation Information
Table 181. GlaxoSmithKline plc. Description and Business Overview
Table 182. GlaxoSmithKline plc. Expectorant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. GlaxoSmithKline plc. Expectorant Drug Product
Table 184. GlaxoSmithKline plc. Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Expectorant Drug Distributors List
Table 188. Expectorant Drug Customers List
Table 189. Expectorant Drug Market Trends
Table 190. Expectorant Drug Market Drivers
Table 191. Expectorant Drug Market Challenges
Table 192. Expectorant Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Expectorant Drug
Figure 2. Global Expectorant Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Expectorant Drug Market Share by Type in 2023 & 2030
Figure 4. Oral Solid Product Picture
Figure 5. Oral Liquid Product Picture
Figure 6. Inhalants Product Picture
Figure 7. Global Expectorant Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Expectorant Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Expectorant Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Expectorant Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Expectorant Drug Sales (2019-2030) & (K Units)
Figure 15. Global Expectorant Drug Average Price (US$/Unit) & (2019-2030)
Figure 16. Expectorant Drug Report Years Considered
Figure 17. Expectorant Drug Sales Share by Manufacturers in 2023
Figure 18. Global Expectorant Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Expectorant Drug Players: Market Share by Revenue in 2023
Figure 20. Expectorant Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Expectorant Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Expectorant Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Expectorant Drug Revenue Market Share by Country (2019-2030)
Figure 24. United States Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Expectorant Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Expectorant Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Expectorant Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Expectorant Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Expectorant Drug Sales Market Share by Country (2019-2030)
Figure 43. Latin America Expectorant Drug Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Expectorant Drug Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Expectorant Drug Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Expectorant Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Expectorant Drug by Type (2019-2030)
Figure 53. Global Revenue Market Share of Expectorant Drug by Type (2019-2030)
Figure 54. Global Expectorant Drug Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Expectorant Drug by Application (2019-2030)
Figure 56. Global Revenue Market Share of Expectorant Drug by Application (2019-2030)
Figure 57. Global Expectorant Drug Price (US$/Unit) by Application (2019-2030)
Figure 58. Expectorant Drug Value Chain
Figure 59. Expectorant Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
